发明名称 NEURONAL NICOTINIC AGONISTS AND METHODS OF USE
摘要 An embodiment relates to a selective agonist of neuronal nicotinic acetylcholine receptor α7 subtype, a pharmaceutically suitable salt, prodrug, or a metabolite thereof, for the prevention and treatment of diseases and conditions that are mediated by nicotinic acetylcholine receptors, and methods of use thereof. Another embodiment is a method of administering a pharmaceutically effective amount of a selective agonist of neuronal nicotinic acetylcholine receptor α7 subtype, or a pharmaceutically suitable salt, prodrug, or a metabolite thereof, to a mammal in need thereof.
申请公布号 US2015313891(A1) 申请公布日期 2015.11.05
申请号 US201514702308 申请日期 2015.05.01
申请人 AbbVie Inc. 发明人 Decker Michael W.
分类号 A61K31/4748;A61K31/439 主分类号 A61K31/4748
代理机构 代理人
主权项 1. Use of a selective agonist of neuronal nicotinic acetylcholine receptor α7 subtype for the preparation of a medicament for treating, preventing or delaying progression of dyskinesia associated with dopamine agonist therapy in Parkinson's disease.
地址 North Chicago IL US